The store will not work correctly when cookies are disabled.
3-Hydroxy-1-methyl-5-((phenylthio)methyl)-1H-pyrazole-4-carboxylic acid
ID: ALA4514633
PubChem CID: 155539488
Max Phase: Preclinical
Molecular Formula: C12H12N2O3S
Molecular Weight: 264.31
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cn1nc(O)c(C(=O)O)c1CSc1ccccc1
Standard InChI: InChI=1S/C12H12N2O3S/c1-14-9(10(12(16)17)11(15)13-14)7-18-8-5-3-2-4-6-8/h2-6H,7H2,1H3,(H,13,15)(H,16,17)
Standard InChI Key: ZHAYGNAAJUYMAL-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 19 0 0 0 0 0 0 0 0999 V2000
39.1187 -10.6157 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.7816 -10.1378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5273 -9.3569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7101 -9.3569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.4557 -10.1378 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.2334 -8.9457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2304 -8.1285 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.1187 -11.4328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2300 -8.6956 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.9427 -9.3516 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.4840 -10.5451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4824 -11.3623 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
41.1893 -11.7722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.1854 -12.5891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.8915 -12.9990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.6010 -12.5917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.5999 -11.7703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.8933 -11.3641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4 5 2 0
2 3 2 0
1 2 1 0
3 4 1 0
5 1 1 0
3 6 1 0
6 7 2 0
1 8 1 0
4 9 1 0
6 10 1 0
2 11 1 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 264.31 | Molecular Weight (Monoisotopic): 264.0569 | AlogP: 2.12 | #Rotatable Bonds: 4 |
Polar Surface Area: 75.35 | Molecular Species: ACID | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.07 | CX Basic pKa: 0.01 | CX LogP: 3.01 | CX LogD: -1.83 |
Aromatic Rings: 2 | Heavy Atoms: 18 | QED Weighted: 0.83 | Np Likeness Score: -1.01 |
References
1. Pippione AC, Sainas S, Goyal P, Fritzson I, Cassiano GC, Giraudo A, Giorgis M, Tavella TA, Bagnati R, Rolando B, Caing-Carlsson R, Costa FTM, Andrade CH, Al-Karadaghi S, Boschi D, Friemann R, Lolli ML.. (2019) Hydroxyazole scaffold-based Plasmodium falciparum dihydroorotate dehydrogenase inhibitors: Synthesis, biological evaluation and X-ray structural studies., 163 [PMID:30529545] [10.1016/j.ejmech.2018.11.044] |